"We look forward to working with Dr. Rosenberg and his colleagues at the NCI on this research project."
Genesis Biopharma has been independently developing Contego™, the Company's autologous cell therapy product candidate for the treatment of metastatic melanoma, and has partnered with members of its Scientific and Medical Advisory Board for advice and assistance. Genesis Biopharma's Scientific and Medical Advisory Board is comprised of leading oncology researchers and clinicians, and includes:
- Cassian Yee, M.D., of the Fred Hutchinson Cancer Research Center
- James Mule, Ph.D. and Jeffrey Weber, M.D., Ph.D., of the H. Lee Moffitt Cancer Center & Research Institute
- Patrick Hwu, M.D. and Laszlo Radvanyi, Ph.D., of MD Anderson Cancer Center
- Daniel Powell, Ph.D., of the University of Pennsylvania School of Medicine
- Mario Sznol, M.D., of Yale University School of Medicine
- David DiGiusto, Ph.D., of the City of Hope
Genesis Biopharma also recently announced the signing of a process development and scale-up agreement relating to the manufacture of Contego with Lonza, one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Lonza is also one of the largest manufacturers of autologous cell therapy products.
About Genesis Biopharma, Inc.
Genesis Biopharma, Inc. is a development-stage biotechnology company engaged in the development of targeted cancer immunotherapies. For more information about the company, visit www.genesis-biopharma.com.
The foregoing announcement contains forward-looking statements that can be identified by such terminology as "expects," "hopes," "potential," "suggests," "bodes," "may," "should," "could," or similar expressions.
Page: 1 2 3 Related biology technology :1
|SOURCE Genesis Biopharma, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. Genesis Biopharma Names Former Member of the Joint Chiefs of Staff General Merrill McPeak to Board of Directors2
. Genesis Biopharma Names David Voyticky to Board of Directors3
. Genesis Biopharma Director William H. Andrews, Ph.D., Profiled in Popular Science Feature Story4
. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board5
. Genesis Biopharma Conference Call and Webcast Reminder6
. Genesis Biosciences Receives Pulire Innovation Award for e card Sanitary Bin Treatment Product7
. Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharmas Scientific and Medical Advisory Board8
. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board9
. ThermoGenesis Announces China Customer Implements Cord Blood Products10
. Tissue Genesis Begins FDA-Approved Clinical Trial11
. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation